Nasway Use As an Independent Adverse Prognostic Factor in Oral Squamous Cell Carcinoma: A Retrospective Cohort Study from Uzbekistan. JOC 2026, 25 (1), 671-679. https://doi.org/10.66838/J.Carcinog.25.1.671-679.